Vaccinia virus recombinant that expresses the herpes simplex virus type 1 glycoprotein d gene protects mice against lethal challenge by herpes simplex virus type 1 or herpes simplex type 2 and the establishment of a latent ganglionic infection by herpes simplex virus type 1
Cremer, K.; Wohlenberg, C.; Notkins, A.L.; Mackett, M.; Moss, B.
Lerner, R A , R M Chanock And F Brown (Ed ) Vaccines 85 Molecular And Chemical Basis Of Resistance to Parasitic, Bacterial, And Viral Diseases; Meeting, 1983 Xxi+407p Cold Spring Harbor Laboratory: Cold Spring Harbor, N Y , Usa Illus Paper 169-174
1985
Accession: 029526982
Full Text Article emailed within 1 workday: $29.90
Related References
Weir, J.P.; Bennett, M.; Allen, E.M.; Elkins, K.L.; Martin, S.; Rouse, B.T. 1989: Recombinant vaccinia virus expressing the herpes simplex virus type 1 glycoprotein C protects mice against herpes simplex virus challenge Journal of General Virology 70: 2587-2594Kimura, S.; Okazaki, K. 1984: Expression of a herpes simplex virus glycoprotein in two clonal lines of hamster cells transformed by herpes simplex virus type 2 - Expression d'une glycoprotéine du virus herpès simplex dans deux lignées clonales de cellules de hamster transformées par le virus herpès simplex de type 2 Gann 75(4): 317-324
Shavrina Asher, L.V.; Walz, M.A. 1977: Effect of immunization on the development of a latent ganglionic infection in mice challenged intra vaginally with herpes simplex virus type 1 and herpes simplex virus type 2 Abstracts of the Annual Meeting of the American Society for Microbiology 77: 331
Wilkie, N.M.; Stow, N.D.; Marsden, H.S.; Preston, V.; Cortini, R.; Timbury, M.C.; Subak Sharpe, J.H. 1979: Physical mapping of herpes simplex virus coded functions and poly peptides by marker rescue and analysis of herpes simplex virus type 1 herpes simplex virus type 2 inter typic recombinants De-The, G , W Henle And F Rapp (Ed ) IARC (International Agency For Research on Cancer) Science Publications, No 24 Oncogenesis And Herpesviruses, Iii Part 1: Dna Of Herpesviruses, Viral Antigens, Cell-Virus Interaction; Proceedings Of The 3rd International Symposium, Cambridge, Mass , Usa, July 25-29, 1977 Lv+580p International Agency For Research on Cancer: Lyon, France Illus P11-32, 1978
Cantin, E.M.; Eberle, R.; Baldick, J.L.; Moss, B.; Willey, D.E.; Notkins, A.L.; Openshaw, H. 1987: Expression of herpes simplex virus 1 glycoprotein B by a recombinant vaccinia virus and protection of mice against lethal herpes simplex virus 1 infection Proceedings of the National Academy of Sciences of the United States of America 84(16): 5908-5912
Cremer, K.J.; Mackett, M.; Wohlenberg, C.; Notkins, A.L.; Moss, B. 1985: Vaccinia virus recombinant expressing herpes simplex virus type 1 glycoprotein D prevents latent herpes in mice Science 228(4700): 737-740
Russell, R.G.; Larsen, H.S.; Rouse, B.T. 1982: Protection of mice against lethal herpes simplex virus type 1 infection by herpes simplex virus type 1 primed spleen cells re stimulated in vitro Federation Proceedings 41(3): Abstract 1758
Foster, C.S.; Wells, P.A.; Sandstrom, I.K.; Opremcak, E.M.; Thompson, P.; Daigle, J.; Millin, J. 1986: Subcutaneous immunization with purified herpes simplex virus glycoprotein d protects against keratitis and latency following corneal challenge with herpes simplex virus type 1 IOVS Investigative Ophthalmology and Visual Science 27(3): 114
McKendall, R.R. 1977: Efficacy of herpes simplex virus type 1 immunization in protecting against acute and latent infection by herpes simplex virus type 2 in mice Infection and Immunity 16(2): 717-719
Carter, V.C.; Jennings, S.R.; Rice, P.L.; Tevethia, S.S. 1984: Mapping of a herpes simplex virus type 2-encoded function that affects the susceptibility of herpes simplex virus-infected target cells to lysis by herpes simplex virus-specific cytotoxic T lymphocytes Journal of Virology 49(3): 766-771
Ritchie, M.H.; Oakes, J.E.; Lausch, R.N. 1993: Passive transfer of anti-herpes simplex virus type 2 monoclonal and polyclonal antibodies protect against herpes simplex virus type 1-induced but not herpes simplex virus type 2-induced stromal keratitis IOVS Investigative Ophthalmology and Visual Science 34(8): 2460-2468
Cantin, E.M.; Willey, D.E.; Mclaughlin Taylor, E.; Eberle, R.; Openshaw, H. 1988: Immunization of mice with a vaccinia recombinant virus which expresses the glycoprotein b gene of herpes simplex virus type 1 Lasky, L (Ed ) Ucla (University Of California-Los Angeles) Symposia on Molecular And Cellular Biology New Series, Vol 84 Technological Advances in Vaccine Development; Genentech, Ortho, Smith Kline And French-Ucla Symposium, Park City, Utah, Usa, January 30-February 6, Xxviii+691p Alan R Liss, Inc : New York, New York, Usa Illus 215-222
Luo, C.; Goshima, F.; Kamakura, M.; Mutoh, Y.; Iwata, S.; Kimura, H.; Nishiyama, Y. 2012: Immunization with a highly attenuated replication-competent herpes simplex virus type 1 mutant, HF10, protects mice from genital disease caused by herpes simplex virus type 2 Frontiers in Microbiology 3: 158
Althof, F.; Mechtersheimer, M.; Richter, M.; Dietz, A. 2000: Ein Herpes-simplex-Virus Typ 1-induzierter, Tumor im Vestibulum nasi: Die Problematik der Resistenzentwicklung von Herpes-simplex-Viren im Rahmen einer chronisch-lymphatischen B-Zell-Leukämie - Herpes simplex virus type 1-induced, tumor in the nasal vestibule.the problem of resistance development of herpes simplex in a patient with chronic lymphatic B-cell leukemia Hno. Hals-, Nasen-, Ohrenarzte 48(2): 147-151
Frenkel, L.M.; Smith, C.M.; Rose, J.M.; Coates, S.R. 1990: Comparison of recombinant herpes simplex virus type 2 specific glycoprotein g with herpes simplex virus for the detection of herpes simplex type 2 specific antibodies Abstracts of the Annual Meeting of the American Society for Microbiology 90: 349
Brans, R. 2010: Evaluation eines dominantnegativen rekombinanten Herpes-simplex-Virus (HSV) Typ 1 als Impfstoff gegen Herpes genitalis bei Mäusen und Meerschweinchen - Evaluation of a dominant-negative recombinant herpes simplex virus (HSV) type 1 as a vaccine against genital herpes in mice und guinea pigs der Hautarzt 61(12): 1073-1077
Ghiasi, H.; Cai, S.; Slanina, S.; Nesburn, A.B.; Wechsler, S.L. 1997: Nonneutralizing antibody against the glycoprotein K of herpes simplex virus type-1 exacerbates herpes simplex virus type-1-induced corneal scarring in various virus-mouse strain combinations IOVS Investigative Ophthalmology and Visual Science 38(6): 1213-1221
Warner, M.S.; Geraghty, R.J.; Martinez, W.M.; Montgomery, R.I.; Whitbeck, J.C.; Xu, R.; Eisenberg, R.J.; Cohen, G.H.; Spear, P.G. 1998: A cell surface protein with herpesvirus entry activity (HveB) confers susceptibility to infection by mutants of herpes simplex virus type 1, herpes simplex virus type 2, and pseudorabies virus Virology 246(1): 179-189
Mugo, N.; Dadabhai, S.S.; Bunnell, R.; Williamson, J.; Bennett, E.; Baya, I.; Akinyi, N.; Mohamed, I.; Kaiser, R. 2011: Prevalence of herpes simplex virus type 2 infection, human immunodeficiency virus/herpes simplex virus type 2 coinfection, and associated risk factors in a national, population-based survey in Kenya Sexually Transmitted Diseases 38(11): 1059-1066
Darai, G.; Fluegel, R.M.; Zoeller, L.; Moeller, P.; Hofmann, W.; Schwaier, A. 1980: Super infection with wild type herpes simplex virus type 1 of animals previously infected with temperature sensitive mutants of herpes simplex virus type 2 changes the physiological properties of recovered viruses Zentralblatt für Bakteriologie, Mikrobiologie und Hygiene, 1. Abteilung Originale, A, Medizinische Mikrobiologie, Infektionskrankheiten, Virologie, Parasitologie 248(1): 13